GSK to nearly double cancer drugs in trials, WSJ reports
Today 07:44
GSK to nearly double cancer drugs in trials, WSJ reports Oct 27 (Reuters) - GSK GSK.L expects to nearly double the number of cancer medicines it is testing in clinical trials next year, the Wall Street Journal reported on Tuesday, citing an interview with a scientist at the British drugmaker.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Harikrishnan Nair)
Recent news on GSK
See all newsGSK to nearly double cancer drugs in trials next year, WSJ reports (updated)
GSK to nearly double cancer drugs in trials, WSJ reports
Brief: Gsk Expects To Nearly Double The Number Of Cancer Medicines It Is Testing In Clinical Trials Next Year- WSJ
GSK, Hansoh's bone cancer drug delays disease progression in late-stage China study
Director/PDMR Shareholding